Published in Elder Law Weekly, September 14th, 2005
The researchers collected blood from 100 apparently healthy females and 61 ovarian cancer patients. The cut off level for DR-70 was set at 1.2 mcg/ml. The specificity of DR-70 at this level was 100%...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.